scholarly journals High-intensity focused ultrasonic ablation of breast cancer

2018 ◽  
Vol 5 (3) ◽  
pp. 67-76
Author(s):  
L. I. Moskvicheva

Breast cancer is the most frequent and socially signifi cant malignant tumor disease of the female popula on of the Russian Federa on. At present, for the treatment of this pathology, the methods of the organ-preserving surgical manual allowing to achieve the maximum cosme c eff ect along with the observance of the principles of cancer safety are ge  ng more and more developed,. In recent decades, researchers from diff erent countries demonstrate the feasibility and technical safety of various mini-invasive methods of thermal abla on of early stages of breast cancer, characterized by rela ve simplicity of implementa on, excellent cosme c results, short-term rehabilita on of pa ents. These include hyperthermic techniques (radiofrequency, microwave, laser abla on) and hypothermic method (cryoabla on). Each technique has unique characteris cs of impact on the tumor and is performed under the control of ultrasound, computer tomography or magne c resonance imaging. The technical success of these abla on techniques is achieved in 93–98% of cases. Complete tumor necrosis a er radiofrequency abla on is observed in 76–100% of pa ents with breast cancer, laser abla on – in 13–76%, microwave abla on – in 0–8%, cryoabla on – in 36–83%. The frequency of development of specifi c complica ons of local thermal destruc on is 4–13%. To date, there is only one method of noninvasive extracorporeal thermal abla on of tumors of diff erent localiza on – high-intensity focused ultrasound therapy, the eff ec veness and safety of which as a method of local destruc on of benign and malignant tumors of the breast demonstrated by many authors. Like all methods of thermal abla on, high-intensity focused ultrasound therapy has its limita ons, complica ons and disadvantages. This ar cle presents a literary review that highlights the possibili es of this method of local destruc on in pa ents with malignant tumors of the breast.

2020 ◽  
Vol 27 ◽  
Author(s):  
Loreto B. Feril ◽  
Rodney L. Fernan ◽  
Katsuro Tachibana

: High-intensity focused ultrasound (HIFU) is a noninvasive method of ablating malignant tumors. This paper will review the current clinical application of HIFU specially in the treatment of breast cancer. In addition to clinical studies, this review will also look into some basic studies that could address the technical issues related to this modality. In general, HIFU is considered to be safe being noninvasive and non-ionizing. Complication occurrence rate is low and repeated treatment is possible, making it an attractive option for some patients. However, for more than two decades since it was first used to treat breast cancer, clinical studies on HIFU still remain at the investigative stage and are only available in several centers. Reasons contributing to such few studies on HIFU include lack of specialized medical team and bioengineering technical staff, and breast cancer-dedicated imaging-HIFU platform to attain positive outcome. Despite these circumstances, we believe that HIFU will eventually become the treatment of choice for most breast cancer patients in the near future.


2012 ◽  
Vol 142 (5) ◽  
pp. S-343 ◽  
Author(s):  
Atsushi Sofuni ◽  
Fuminori Moriyasu ◽  
Takatomo Sano ◽  
Fumihide Itokawa ◽  
Kentaro Ishii ◽  
...  

2018 ◽  
Vol 42 (7) ◽  
pp. 450-456
Author(s):  
A. Durán-Rivera ◽  
A. Montoliu García ◽  
J. Juan Escudero ◽  
P. Garrido Abad ◽  
M. Fernández Arjona ◽  
...  

RSC Advances ◽  
2018 ◽  
Vol 8 (9) ◽  
pp. 4514-4524 ◽  
Author(s):  
Minghua Yao ◽  
Ming Ma ◽  
Huixiong Xu ◽  
Xiaoxia Pan ◽  
Guang Xu ◽  
...  

A nanometer-sized inor-ganic/organic hybrid enhancement agent is constructed for photoacoustic imaging-guided high intensity focused ultrasound therapy.


Sign in / Sign up

Export Citation Format

Share Document